(Q38017389)

27 August 2017

title

Clostridium difficile: development of a novel candidate vaccine (English)

1 reference

27 August 2017

main subject

Clostridium difficile

0 references

1 reference

Christine Luxemburger

3

object named as

Christine Luxemburger

0 references

author name string

Ginamarie Foglia

1

1 reference

27 August 2017

Siddhi Shah

2

1 reference

27 August 2017

Christine Luxemburger

3

1 reference

27 August 2017

Patricia J Freda Pietrobon

4

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 June 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

30

1 reference

27 August 2017

issue

29

1 reference

27 August 2017

page(s)

4307-4309

1 reference

The search for effective treatment of Clostridium difficile infection

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Emergence of Clostridium difficile-associated disease in North America and Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Clostridium difficile infection: epidemiology, risk factors and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Clostridium difficile infection in Europe: a hospital-based survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Update on Clostridium difficile infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Treatment of Clostridium difficile-associated disease: old therapies and new strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Treatment with monoclonal antibodies against Clostridium difficile toxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

Toxin B is essential for virulence of Clostridium difficile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.056

10.1016/J.VACCINE.2012.01.056

7 January 2021

Identifiers

DOI

1 reference

27 August 2017

1 reference